SCHECHTER JONATHAN purchased 45.3% of their position (60K shares) of PHARMACYTE BIOTECH, INC. on the open market
Open‑market purchase worth $48.2K — a major conviction buy. The strongest form of insider conviction signal.
P · 3 purchases
Filed: 1/7/2026ACC: 0001683168-26-000147
Director
Since Aug 2022
+60K
Net shares
Net buyer
$48.2K
Total acquired
3
Open market trades
3B · 0S
3
Total transactions
60K acquired
Non-Derivative Transactions3
Common Stock
Direct
Shares
+20K
Price / share
$0.78
Trade value
$15.55K
% of position
15.1%
1/5/2026
132.50K→152.50K
Common Stock
Direct
Shares
+20K
Price / share
$0.79
Trade value
$15.81K
% of position
13.1%
1/6/2026
152.50K→172.50K
Common Stock
Direct
Shares
+20K
Price / share
$0.84
Trade value
$16.87K
% of position
11.6%
1/7/2026
172.50K→192.50K
Total
Net shares
+60K
Net value
$48.23K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/5/2026 | P · Purchase | +20K | $0.78 | $15.55K | 15.1% | 132.50K | 152.50K |
| Common Stock Direct | 1/6/2026 | P · Purchase | +20K | $0.79 | $15.81K | 13.1% | 152.50K | 172.50K |
| Common Stock Direct | 1/7/2026 | P · Purchase | +20K | $0.84 | $16.87K | 11.6% | 172.50K | 192.50K |
| Total | +60K | $48.23K | ||||||
Derivative Transactions0
No derivative transactions reported